10 top patient groups oppose REGROW Act that would gut stem cell oversight

The Niche, Knoepfler lab stem cell blog. June 1, 2016.

The REGROW Act would drastically weaken FDA regulation of experimental stem cell therapies.

Patient Groups Opposing REGROW

Cystic Fibrosis Foundation
Friedreich’s Ataxia Research Alliance
Friends of Cancer Research
Global Genes
Michael J. Fox Foundation for Parkinson’s Research
Myotonic Dystrophy Foundation
National MS Society
National Organization for Rare Disorders
National Patient Advocate Foundation
Prevent Cancer Foundation

 10 top patient groups oppose REGROW Act that would gut stem cell oversight